Evidence map›Paper›PMID 33545059›Full record

ArticleMolecular cell2021

Human DDK rescues stalled forks and counteracts checkpoint inhibition at unfired origins to complete DNA replication.

Mathew J K Jones, Camille Gelot, Stephanie Munk, Amnon Koren, Yoshitaka Kawasoe, Kelly A George, Ruth E Santos, Jesper V Olsen, Steven A McCarroll, Mark G Frattini and 2 more

Open access · greenAbstract read
In one paragraph

Article in Molecular cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. The yeast Dbf4 ZnCurrent genetics · 2022
    Article
  19. DNA damage responses that enhance resilience to replication stress.Cellular and molecular life sciences : CMLS · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Mathew J K JonesMolecular Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, QLD 4102, Australia. Electronic address: mathew.jones@uq.edu.au.
Camille GelotMolecular Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Stephanie MunkUniversity of Copenhagen and Novo Nordisk Foundation Center for Protein Research, Copenhagen 2200, Denmark.
Amnon KorenCornell University, Department of Molecular Biology and Genetics, Ithaca, NY 14853, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Yoshitaka KawasoeGraduate School of Science, Kyushu University, Nishi-ku, Fukuoka 819-0395, Japan.
Kelly A GeorgeMolecular Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Ruth E SantosDivision of Hematology/Oncology, Columbia University Medical Center, New York, NY 10032, USA.
Jesper V OlsenUniversity of Copenhagen and Novo Nordisk Foundation Center for Protein Research, Copenhagen 2200, Denmark.
Steven A McCarrollDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Mark G FrattiniDivision of Hematology/Oncology, Columbia University Medical Center, New York, NY 10032, USA.
Tatsuro S TakahashiGraduate School of Science, Kyushu University, Nishi-ku, Fukuoka 819-0395, Japan.
Prasad V JallepalliMolecular Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: jallepap@mskcc.org.
Memorial Sloan Kettering Cancer Center · USColumbia University Irving Medical Center · USHarvard University · USKyushu University · JPNovo Nordisk Foundation · DKUniversity of Queensland · AU

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Regulation of Chromosome Segregation in Human CellsR01GM094972 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI JALLEPALLI, PRASAD V · 2010 to 2021
$5.3M
Personal mutational landscapes encoded in our DNADP2GM123495 · NIGMS · CORNELL UNIVERSITY · PI KOREN, AMNON · 2016 to 2016
$2.3M
NCI NIH HHS P30 CA008748NIGMS NIH HHS DP2 GM123495NIGMS NIH HHS R01 GM094972
6 · The paper itself

Abstract

Eukaryotic genomes replicate via spatially and temporally regulated origin firing. Cyclin-dependent kinase (CDK) and Dbf4-dependent kinase (DDK) promote origin firing, whereas the S phase checkpoint limits firing to prevent nucleotide and RPA exhaustion. We used chemical genetics to interrogate human DDK with maximum precision, dissect its relationship with the S phase checkpoint, and identify DDK substrates. We show that DDK inhibition (DDKi) leads to graded suppression of origin firing and fork arrest. S phase checkpoint inhibition rescued origin firing in DDKi cells and DDK-depleted Xenopus egg extracts. DDKi also impairs RPA loading, nascent-strand protection, and fork restart. Via quantitative phosphoproteomics, we identify the BRCA1-associated (BRCA1-A) complex subunit MERIT40 and the cohesin accessory subunit PDS5B as DDK effectors in fork protection and restart. Phosphorylation neutralizes autoinhibition mediated by intrinsically disordered regions in both substrates. Our results reveal mechanisms through which DDK controls the duplication of large vertebrate genomes.

Indexed as

DNA ReplicationReplication OriginAdaptor Proteins, Signal TransducingAnimalsAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCheckpoint Kinase 1DNA-Binding ProteinsFemaleHCT116 CellsHEK293 CellsHeLa CellsHumansPhosphorylationProtein Kinase InhibitorsProtein Serine-Threonine KinasesAdaptor Proteins, Signal TransducingAtaxia Telangiectasia Mutated ProteinsATR protein, humanBABAM1 protein, humanCDC7 protein, humanCell Cycle ProteinsCheckpoint Kinase 1CHEK1 protein, humanDNA-Binding ProteinsPDS5B protein, humanProtein Kinase InhibitorsProtein Serine-Threonine KinasesTranscription FactorsATRCdc7chemical geneticsDDKDNA replicationMERIT40PDS5Bphosphoproteomics

Identifiers

PMID33545059
PMCPMC8211091
OpenAlexW3128056875

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.